BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11013220)

  • 1. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
    Feng XH; Zhang Y; Wu RY; Derynck R
    Genes Dev; 1998 Jul; 12(14):2153-63. PubMed ID: 9679060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.
    Janknecht R; Wells NJ; Hunter T
    Genes Dev; 1998 Jul; 12(14):2114-9. PubMed ID: 9679056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling.
    Kim RH; Lieberman MB; Lee R; Shin KH; Mehrazarin S; Oh JE; Park NH; Kang MK
    Exp Cell Res; 2010 Oct; 316(16):2600-8. PubMed ID: 20630502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
    Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.
    Penheiter SG; Mitchell H; Garamszegi N; Edens M; Doré JJ; Leof EB
    Mol Cell Biol; 2002 Jul; 22(13):4750-9. PubMed ID: 12052882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
    Datta PK; Moses HL
    Mol Cell Biol; 2000 May; 20(9):3157-67. PubMed ID: 10757800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.
    Frederick JP; Liberati NT; Waddell DS; Shi Y; Wang XF
    Mol Cell Biol; 2004 Mar; 24(6):2546-59. PubMed ID: 14993291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter.
    Qing J; Liu C; Choy L; Wu RY; Pagano JS; Derynck R
    Mol Cell Biol; 2004 Feb; 24(3):1411-25. PubMed ID: 14729983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.
    Chen S; Kulik M; Lechleider RJ
    Nucleic Acids Res; 2003 Feb; 31(4):1302-10. PubMed ID: 12582250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
    Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
    EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA.
    Miura S; Takeshita T; Asao H; Kimura Y; Murata K; Sasaki Y; Hanai JI; Beppu H; Tsukazaki T; Wrana JL; Miyazono K; Sugamura K
    Mol Cell Biol; 2000 Dec; 20(24):9346-55. PubMed ID: 11094085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling.
    Zhou S; Lechpammer S; Greenberger JS; Glowacki J
    J Biol Chem; 2005 Jun; 280(24):22688-96. PubMed ID: 15845540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.
    Wilkes MC; Murphy SJ; Garamszegi N; Leof EB
    Mol Cell Biol; 2003 Dec; 23(23):8878-89. PubMed ID: 14612425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical model of gene regulation by transforming growth factor beta.
    Yang YC; Piek E; Zavadil J; Liang D; Xie D; Heyer J; Pavlidis P; Kucherlapati R; Roberts AB; Böttinger EP
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10269-74. PubMed ID: 12930890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.
    Wong C; Rougier-Chapman EM; Frederick JP; Datto MB; Liberati NT; Li JM; Wang XF
    Mol Cell Biol; 1999 Mar; 19(3):1821-30. PubMed ID: 10022869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad3 as a mediator of the fibrotic response.
    Flanders KC
    Int J Exp Pathol; 2004 Apr; 85(2):47-64. PubMed ID: 15154911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
    Kretzschmar M; Doody J; Timokhina I; Massagué J
    Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.